A Study on Correlation between Serum Cortisol and Stroke Severity with Serum Cortisol
DOI:
https://doi.org/10.48165/tjv85p31Keywords:
Acute ischemic stroke, HPA axis, serum cortisol,, clinical severity, Functional outcome, stroke scalesAbstract
Background: The stress response that occurs after the event of acute stroke causes the activation of the hypothalamo–pituitary–adrenal (HPA) axis. Certain studies have found that increased serum cortisol level in patients with acute stroke is related to larger infarct volume, greater stroke severity and poor outcome, including death. Subjects and Methods: About 50 new cases of acute ischemic stroke patients, within 72 hours of the acute neurological event , who were admitted in the Sridevi Medical College & Hospital were included in the study. The study was conducted for a period of 6 months.(June 2018-December 2018). CT Brain was taken during admission to confirm acute ischemic stroke. NIHSS (National Institute of Health Stroke Scale)score for all the patients were assessed for severity at the time of admission. Results: Of the 50 cases, serum cortisol level of 23 cases were within normal limits(</=690nmol/L) of which 65.2% had NIHSS score of less than or equal to 6 and 34.8% of the cases had NIHSS score more than 6. Conclusion: Among the patients with acute ischemic stroke ,high serum cortisol levels at the time of admission correlates with,1. Clinical severity which is assessed by National Institute of Health Stroke Scale and 2, Poor prognosis and functional outcome after 15 days which is assessed by Modified Rankin Scale.
References
1. Otte C, Hart S, Neylan TC, Marmar CR, Yaffe K, Mohr DC. A meta analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology. 2005;30:80–91
2. MacLullich A, Deary IJ, Starr JM, Ferguson KJ, Wardlaw JM, Seckl JR. Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology. 2005;30(5):505–515.
3. Miller AH, Spencer RL, McEwen BS, Stein M. Depression, adrenal steroids and the immune system. Ann Intern Med. 1993;25(5):481– 487.
4. Mitchell A. Clinical implications of poststroke hypothalamo-pituitary adrenal axis dysfunction: a critical literature review. J Stroke Cerebrovascular Dis. 1997;6(6):377–388.
5. Brown E, Woolston D, Frol A, Bobadilla L, Khan DA, Hanczyc M, Rush AJ, Fleckenstein J, Babcock E, Cullum CM. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55:538–545.
6. van Munster B, Bisschop PH, Zwinderman AH, Korevaar JC, Endert E, Wiersinga WJ, van Oosten HE, Goslings JC, de Rooij SE. Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn. 2010;74:18–23.
7. Pearson A, de Vries A, Middleton SD, Gillies F, White TO, Armstrong IR, Andrew R, Seckl JR, MacLullich AM. Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls. BMC Res Notes. 2010;3:33.
8. Lee B, Thomas AG, McAtee MJ. Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry. 2007;64:810–818.
9. Kumari M, et al. Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study. J Clin Endocrinol Metab. 2011;96(5):1478–1485.
10. 10. Franceschini R, et al. Endocrine abnormalities and outcome of ischaemic stroke. Biomed Pharmacother. 2001;55(8):458–465.
